Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)
CNY 21.0
(0.92%)
CNY 21.0
(0.92%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 116.82 Million CNY | 356.72% |
| 2022 | 27.65 Million CNY | 110.38% |
| 2021 | 13.14 Million CNY | 615.14% |
| 2020 | 1.83 Million CNY | -84.0% |
| 2019 | 11.48 Million CNY | 4.13% |
| 2018 | 11.03 Million CNY | 278.27% |
| 2017 | 2.91 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 19.87 Million CNY | 108.75% |
| 2024 Q1 | 66.67 Million CNY | 145.03% |
| 2024 Q2 | 9.52 Million CNY | -85.72% |
| 2023 Q2 | 85.76 Million CNY | 2034.8% |
| 2023 FY | 126.31 Million CNY | 356.72% |
| 2023 Q3 | 9.32 Million CNY | -89.13% |
| 2023 Q1 | 4.01 Million CNY | -44.97% |
| 2023 Q4 | 27.2 Million CNY | 191.75% |
| 2022 Q3 | 9.36 Million CNY | 34.14% |
| 2022 Q2 | 6.98 Million CNY | 74.13% |
| 2022 Q1 | 4 Million CNY | -23.16% |
| 2022 FY | 27.65 Million CNY | 110.38% |
| 2022 Q4 | 7.29 Million CNY | -22.06% |
| 2021 FY | 13.14 Million CNY | 615.14% |
| 2021 Q4 | 5.21 Million CNY | 44.94% |
| 2021 Q3 | 3.6 Million CNY | -15.46% |
| 2021 Q2 | 4.25 Million CNY | 5987.75% |
| 2021 Q1 | 69.95 Thousand CNY | 117.53% |
| 2020 Q4 | -399.02 Thousand CNY | -121.64% |
| 2020 Q3 | 1.84 Million CNY | 0.0% |
| 2020 FY | 1.83 Million CNY | -84.0% |
| 2019 FY | 11.48 Million CNY | 4.13% |
| 2018 FY | 11.03 Million CNY | 278.27% |
| 2017 FY | 2.91 Million CNY | 0.0% |